SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ABTX - Agribiotech -- Ignore unavailable to you. Want to Upgrade?


To: BuzzVA who wrote (7207)1/25/1999 1:23:00 PM
From: Jeff Sutton  Read Replies (2) | Respond to of 8359
 
CC call replay # anyone?



To: BuzzVA who wrote (7207)1/25/1999 1:40:00 PM
From: Big Dog  Respond to of 8359
 
Dear BuzzVA: Thank you for taking the time to post as the conference was going on. The replay will be available at 2:30 p.m. (1-800-475-6701; access code: 430819).

Your comments (for the most part) accurately covered the CC.

A few additions:

The large life science companies are too focused on corn and other crop seeds. The informal process to be pursued by Dr. Thomas will focus on "informing" those companies of the "large" market potential for forage and turf.

The potential partners (10 in all) were concerned with the "integration process" and wanted firmer evidence of how the bio-tech efforts will benefit the marketplace.

The convertible debentures may be purchased back by ABTX once the integration process and sale of unwanted assets proceeds.

Deutsche Bank (Rainey) was not pleased with Dr. Thomas' answer. Deutsche Bank clearly wanted Dr. Thomas to focus on the business as opposed to the extraordinary "informal" strategic alliance process.

Dr. Thomas did not staightforwardly answer Guilford Securities question concerning how operating profits will be affected with and without the $15 million+ restructuring charge relating to the integration process.

Dr. Thomas was clear in answering a question by Graystone Partners that "THERE ARE NO OUTSTANDING ACCOUNTING PROBLEMS." So, once and for all we can put that issue to rest!



To: BuzzVA who wrote (7207)1/25/1999 1:52:00 PM
From: caledonia  Read Replies (1) | Respond to of 8359
 
On a somewhat positive note, all of those shareholders who bought strictly on a takeover possibility are washed out. ABTX will trade strictly on fundamentals, a novel approach in today's market. JT, et al, are licking their wounds. I am giving them a lot of wiggle room because of their relative inexperience in dealing with investors. I will pull the plug when any hint of fraud is revealed. So far, this is not the case. Also, a "strategic equity partner" does not mean a suitor, as many have assumed. The whole merger mania that has enveloped ABTX has been way overdone, IMO. In fact, I was hoping they would stay independent as long as possible. But, keep in mind, this does not preclude any company with presenting an offer. It's just that ABTX will not be the initiator. How can they attract top notch talent (which they have done) if they are on the chopping block? Would you join a company if you knew they were going to be acquired? Three months is a lifetime in today's investment environment. Longer term, I think shareholder value will be maximized by staying independent. But, as evidenced by the price today, a price horizon longer than a few months does not justify buying the stock. Perhaps they should start selling seeds over the internet and change their name to "abtx.com." According to today's mindset, it would be a great value worthy of a stock price in the triple figures! It's all psychology. Remember, when you buy or sell, the investor on the other side of your trade has an opinion that is different from yours. My opinion is definitely in the minority. But, longer term, I think ABTX will be vindicated.